Suyash Agarwal

Suyash Agarwal

Active Director Director DIN 06423971
DIN 06423971 First appointment Nov 2012 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 9 active board seats
Past companies 1 historical roles
Total affiliations 10 Since Nov 2012
Shareholding value •••• Premium profile

About Suyash Agarwal

Data last updated:

Suyash Agarwal is a Director at La Chemico Pvt Ltd (since 2012), Director at Maheshrajka Pharmaceuticals Private Limited (since 2025) and Designated Partner at Oracion Lifeline Llp (since 2017), and holds 6 more current directorships. The companies operate in Pharma, Healthcare and Business Outsourcing. The 2 current companies with reported revenue have a combined latest revenue of ₹83.60 Cr; the largest is La Chemico Pvt Ltd at ₹42.52 Cr (FY 2024). Earlier, Suyash Agarwal was a Director at Nehul Marketing Private Limited (2013–2015).

DIN 06423971
Primary Designation Director
Industry Pharma
First Appointment 26 Nov 2012
Oldest Company Age 42 yrs
Largest company La Chemico Pvt Ltd · ₹42.52 Cr (FY 2024)
Combined revenue ₹83.60 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
La Chemico Pvt Ltd U24231WB1983PTC036999
Director26 Nov 20121983₹42.52 Cr (FY 2024)Active
Director01 Sep 20252014₹41.07 Cr (FY 2024)Active
Designated Partner15 Feb 20172017Active
Designated Partner27 Jun 20162016Active
Designated Partner13 Jan 20152015Active
Tirupati Metals Pvt Ltd U51909WB1985PTC039577
Additional Director14 Mar 20141985Active
Vipasa Agency Private Limited U51909WB2008PTC129369
Director14 Mar 20142008Active
Common Distributors Private Limited U52100WB2010PTC144102
Director14 Mar 20142010Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Nehul Marketing Private Limited U51909WB2013PTC194860
Director19 Jun 20132013₹42.22 Cr (FY 2022)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Maheshrajka Hospitals Llp
Oracion Lifeline Llp
La Chemico Pvt Ltd
Tirupati Metals Pvt Ltd
Premium access

Shareholding and investment profile for Suyash Agarwal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Suyash Agarwal

Suyash Agarwal currently holds 9 directorships: La Chemico Pvt Ltd (Director, since 26 Nov 2012, revenue ₹42.52 Cr (FY 2024)); Maheshrajka Pharmaceuticals Private Limited (Director, since 01 Sep 2025, revenue ₹41.07 Cr (FY 2024)); Oracion Lifeline Llp (Designated Partner, since 15 Feb 2017); Maheshrajka Hospitals Llp (Designated Partner, since 27 Jun 2016); Oracion Solutions Llp (Designated Partner, since 13 Jan 2015); and 4 more.

Suyash Agarwal was first appointed on 26 Nov 2012 as Director at La Chemico Pvt Ltd. The most recent appointment on record is 01 Sep 2025 at Maheshrajka Pharmaceuticals Private Limited.

The 2 current companies of Suyash Agarwal that report revenue have a combined latest revenue of ₹83.60 Cr: La Chemico Pvt Ltd ₹42.52 Cr (FY 2024); Maheshrajka Pharmaceuticals Private Limited ₹41.07 Cr (FY 2024).

Suyash Agarwal held 1 earlier board appointment: Nehul Marketing Private Limited (Director, 19 Jun 2013 to 10 Jul 2015).

The current boards of Suyash Agarwal's companies include Sushil Kumar Agarwal (La Chemico Pvt Ltd), Seema Agarwal (Maheshrajka Pharmaceuticals Private Limited), Bijay Agarwal (Oracion Lifeline Llp), Usha Agarwal (Assemble Dealers Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available